Keeley Teton Advisors LLC lifted its stake in shares of Steris PLC (NYSE:STE) by 41.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,721 shares of the medical equipment provider’s stock after buying an additional 6,332 shares during the period. Keeley Teton Advisors LLC’s holdings in Steris were worth $1,920,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Private Harbour Investment Management & Counsel LLC lifted its position in Steris by 0.4% during the second quarter. Private Harbour Investment Management & Counsel LLC now owns 10,424 shares of the medical equipment provider’s stock valued at $850,000 after purchasing an additional 40 shares during the period. Sawtooth Solutions LLC lifted its position in Steris by 1.3% during the second quarter. Sawtooth Solutions LLC now owns 4,232 shares of the medical equipment provider’s stock valued at $345,000 after purchasing an additional 54 shares during the period. Advisor Group Inc. lifted its position in Steris by 1.4% during the second quarter. Advisor Group Inc. now owns 6,577 shares of the medical equipment provider’s stock valued at $506,000 after purchasing an additional 91 shares during the period. TD Asset Management Inc. lifted its position in Steris by 0.9% during the second quarter. TD Asset Management Inc. now owns 23,540 shares of the medical equipment provider’s stock valued at $1,919,000 after purchasing an additional 200 shares during the period. Finally, Oppenheimer Asset Management Inc. lifted its position in Steris by 1.3% during the second quarter. Oppenheimer Asset Management Inc. now owns 19,439 shares of the medical equipment provider’s stock valued at $1,585,000 after purchasing an additional 254 shares during the period. Institutional investors and hedge funds own 89.45% of the company’s stock.

In other Steris news, insider Michael J. Tokich sold 12,000 shares of Steris stock in a transaction on Wednesday, October 4th. The shares were sold at an average price of $89.75, for a total value of $1,077,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP John Adam Zangerle sold 3,650 shares of Steris stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $88.00, for a total transaction of $321,200.00. The disclosure for this sale can be found here. Insiders sold 36,650 shares of company stock valued at $3,315,200 in the last ninety days. 2.55% of the stock is owned by corporate insiders.

Steris PLC (STE) traded down $0.29 on Friday, reaching $88.45. 317,878 shares of the company’s stock were exchanged, compared to its average volume of 243,949. Steris PLC has a one year low of $65.26 and a one year high of $93.39. The company has a quick ratio of 2.18, a current ratio of 2.80 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $7,547.55, a PE ratio of 22.87 and a beta of 1.27.

Steris (NYSE:STE) last released its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $0.94 earnings per share for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.01). Steris had a net margin of 5.59% and a return on equity of 11.49%. The firm had revenue of $634.20 million during the quarter, compared to analysts’ expectations of $629.02 million. During the same period in the previous year, the firm posted $0.89 EPS. The firm’s quarterly revenue was down 1.9% on a year-over-year basis. analysts predict that Steris PLC will post 4.06 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 20th. Shareholders of record on Wednesday, November 22nd will be issued a $0.31 dividend. The ex-dividend date of this dividend is Tuesday, November 21st. This represents a $1.24 dividend on an annualized basis and a yield of 1.40%. Steris’s payout ratio is 73.81%.

A number of research firms recently issued reports on STE. Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $101.00 target price for the company in a research report on Monday, October 9th. Raymond James Financial boosted their target price on shares of Steris from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. KeyCorp restated a “buy” rating and set a $91.00 target price on shares of Steris in a research report on Tuesday, October 17th. Finally, TD Securities boosted their target price on shares of Steris from C$14.00 to C$16.00 and gave the company a “buy” rating in a research report on Thursday, November 9th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $79.50.

TRADEMARK VIOLATION WARNING: This piece was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/keeley-teton-advisors-llc-boosts-stake-in-steris-plc-ste/1754127.html.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.